Friday, May 3, 2013
Renaissance Seattle Hotel
Seattle, Wash.
The newest ophthalmic innovations with market potential will be the focus of this one-day seminar, which will connect scientists, venture capitalists, pharmaceutical representatives and others. Unlike other investor forums, the meeting will focus on cutting-edge research, rather than established companies.
The event aims to help innovators and scientists better understand how products move through the approval and commercialization pipeline, while giving investors insight into treatments and devices that are nearing readiness for commercial development.
Chair — Nicolas G. Bazan, MD, PhD, FARVO
Topics
| |
• The latest advances in science and translational medicine and how
they could meet market needs
• Clinical/regulatory development issues
• Key concepts of intellectual property
• Funding
• How to start and finance companies
• Pearls from serial entrepreneurs
• Presentations featuring early-state innovations (therapies and devices)
|
See the full program
Who should attend?
| |
• Venture capitalists and angel investors with an interest in biotech
• Pharmaceutical companies interested in learning more about potential
licensing opportunities (especially early stage)
• Aspiring entrepreneurs and start-up organizations
• Scientists and clinicians with a focus on upcoming cutting-edge
innovative mechanistic concepts, novel targets and technologies who
wish to connect with others who can help them move forward
• Market research agencies
• Industry and strategy consultants |
What will you gain?
|
Investors/venture capitalists/analysts will:
|
| |
• Learn about earlier-stage, innovative, cutting-edge
ophthalmic therapies and technologies
• Gain an understanding of these innovations in a scientific,
regulatory and market context
• Take away an objective understanding of potential risks and
opportunities
• Build new relationships with leading scientists and understand
how to partner with them for earlier technologies |
|
Researchers/innovators will:
|
| |
• Benchmark your own innovations and developments alongside others
in key therapeutics, diagnostics and devices
• Learn from the experiences of other innovators
• Have an opportunity to meet and connect with potential investors
• Gain an understanding of the needs and requirements of investors,
major pharmaceutical firms, regulatory bodies and the marketplace |
Vision Innovation and Venture Forum Committee
Nicolas G. Bazan, MD, PhD, FARVO
Robert E. Besthof
Donald C. Hood, PhD, FARVO
Steve Charles, MD, FACS, FICS
Craig E. Crosson, PhD, FARVO
Julia A. Haller, MD, FARVO
Paul P. Lee, MD, JD, FARVO
Sabri Markabi, MD
Samir C. Patel, MD
Joyce Tombran-Tink, PhD, FARVO
Tracy M. Valorie
Gary Walens, RPh
See who spoke at the previous forum.